30. January 2012
Improving Medical Treatment Requires a Risk-based Approach to the Regulation of Clinical Trials
Current EU legislation represents a major hurdle to improving medical treatment due to the straight-jacket of EU legislation that the 2001 Clinical Trials Directive imposes, a group of leading European medical scientists charged today in a position paper1 issued in Brussels and Strasbourg. [more]
ESF provides the scientific, administrative and technical secretariat for COST (European Cooperation in Science and Technology).